Prevalence and recovery of dysphonia in COVID-19 patients requiring intensive care treatment

被引:1
作者
Clayton, Nicola A. [1 ,2 ,3 ,4 ,10 ]
Freeman-Sanderson, Amy [5 ,6 ,7 ,8 ,9 ]
Walker, Elizabeth [5 ,6 ]
机构
[1] Concord Repatriat Gen Hosp, Speech Pathol Dept, Sydney, NSW, Australia
[2] Concord Repatriat Gen Hosp, Intens Care Unit, Sydney, NSW, Australia
[3] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia
[4] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia
[5] Royal Prince Alfred Hosp, Speech Pathol Dept, Sydney, NSW, Australia
[6] Royal Prince Alfred Hosp, Intens Care Unit, Sydney, NSW, Australia
[7] Univ Technol Sydney, Grad Sch Hlth, Sydney, NSW, Australia
[8] George Inst Global Hlth, Crit Care Div, Sydney, NSW, Australia
[9] Monash Univ, Australian & New Zealand Intens Care Res Ctr ANZIC, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia
[10] Concord Repatriat Gen Hosp, Speech Pathol Dept, Bldg 42,Hosp Rd, Concord, NSW 2139, Australia
关键词
COVID-19; SARS-CoV2; Dysphonia; Critically ill; Recovery;
D O I
10.1016/j.aucc.2023.07.043
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Dysphonia and laryngeal pathology are considerable issues in patients hospitalised with COVID-19 with prevalence rates cited between 29% and 79%. Most studies currently are limited to reporting single-institution data with many retrospective. Objectives: The aims of this study were to prospectively explore the following: (i) prevalence; (ii) treatment; and (iii) recovery pattern and outcomes for dysphonia, in patients with COVID-19 requiring intensive care unit (ICU) treatment. Methods: Patients admitted to 26 ICUs over 12 months, diagnosed with COVID-19, treated for survival, and seen by speech-language pathology for clinical voice assessment were considered. Demographic, medical, speech-language pathology treatment, and voice outcome data (grade, roughness, breathiness, asthenia, strain [GRBAS]) were collected on initial consultation and continuously monitored throughout the hospital admission. Findings: Two-hundred and thirty five participants (63% male, median age = 58 yrs) were recruited. Median mechanical ventilation duration and ICU and hospital lengths of stay (LOSs) were 16, 20, and 42 days, respectively. Dysphonia prevalence was 72% (170/235), with 22% (38/170) exhibiting profound impairment (GRBAS score = 3). Of those with dysphonia, rehabilitation was provided in 32% (54/170) cases, with dysphonia recovery by hospital discharge observed in 66% (112/170, median duration = 35 days [interquartile range = 21-61 days]). Twenty-five percent (n = 42) of patients underwent nasendoscopy: oedema (40%, 17/42), granuloma (31%, 13/42), and vocal fold palsy/paresis (26%, 11/42). Presence of dysphonia was inversely associated with the number of intubations (p = 0.002), intubation duration (p = 0.037), ICU LOS (p = 0.003), and hospital LOS (p = 0.009). Conversely, duration of dysphonia was positively associated with the number of intubations (p = 0.012), durations of intubation (p = 0.000), tracheostomy (p = 0.004), mechanical ventilation (p = 0.000), ICU LOS (p = 0.000), and hospital LOS (p = 0.000). More severe dysphonia was associated with younger age (p = 0.045). Proning was not associated with presence (p = 0.075), severity (p = 0.164), or duration (p = 0.738) of dysphonia. Conclusions: Dysphonia and laryngeal pathology are common in critically ill patients with COVID-19 and are associated with younger age and protracted recovery in those with longer critical care interventions. Crown Copyright (c) 2023 Published by Elsevier Ltd on behalf of Australian College of Critical Care Nurses Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/ by-nc-nd/4.0/).
引用
收藏
页码:151 / 157
页数:7
相关论文
共 50 条
  • [41] Intensive Care Unit Admission Parameters for Patients with COVID-19
    Sabaz, Mehmet Suleyman
    Ozdemir, Fatma
    Ozakin, Oguz
    Turkmen, Ulku Aygen
    Dinc, Veysel
    MEDICAL JOURNAL OF BAKIRKOY, 2021, 17 (03) : 254 - 261
  • [42] Pathophysiology and abnormalities of hemostasis in intensive care patients with Covid-19
    Joly, Berangere
    Beranger, Nicolas
    Delrue, Maxime
    Neuwirth, Marie
    Itzhar-Baikian, Nathalie
    Hadj-Ali, Arezki
    Stepanian, Alain
    Veyradier, Agnes
    Siguret, Virginie
    HEMATOLOGIE, 2021, 27 (01): : 10 - 18
  • [43] The Experiences of Intensive Care Nurses in Advocacy of COVID-19 Patients
    Aghaie, Bahman
    Norouzadeh, Reza
    Sharifipour, Ehsan
    Koohpaei, Alireza
    Negarandeh, Reza
    Abbasinia, Mohammad
    JOURNAL OF PATIENT EXPERIENCE, 2021, 8
  • [44] Prevalence of Modified Risk Factors in COVID-19 Patients Admitted to Intensive Care Unit in Kingdom of Bahrain
    Janahi, Jenan Saleh
    Alhamar, Abdulla Khaled
    Kawaja, A. Sana Al
    BAHRAIN MEDICAL BULLETIN, 2024, 46 (03) : 2184 - 2188
  • [45] The use of methylprednisolone in patients with Coronavirus disease 2019 (COVID-19) requiring intensive care hospitalization: a longitudinal observational study
    Doucet, L.
    Hoflack, S.
    van Slambrouck, L.
    Lormans, P.
    ACTA ANAESTHESIOLOGICA BELGICA, 2021, 72 (03) : 129 - 133
  • [46] Prevalence and Characteristics of Hypoxic Hepatitis in COVID-19 Patients in the Intensive Care Unit: A First Retrospective Study
    Huang, Haijun
    Li, Hong
    Chen, Shanshan
    Zhou, Xianlong
    Dai, Xuan
    Wu, Jia
    Zhang, Jun
    Shao, Lina
    Yan, Rong
    Wang, Mingshan
    Wang, Jiafeng
    Tu, Yuexing
    Ge, Minghua
    FRONTIERS IN MEDICINE, 2021, 7
  • [47] COVID-19 recovery: implications for cancer care clinicians
    Delany, Clare
    Milch, Vivienne
    Keefe, Dorothy
    Wong, Zee Wan
    SUPPORTIVE CARE IN CANCER, 2022, 30 (02) : 1003 - 1006
  • [48] COVID-19 recovery: implications for cancer care clinicians
    Clare Delany
    Vivienne Milch
    Dorothy Keefe
    Zee Wan Wong
    Supportive Care in Cancer, 2022, 30 : 1003 - 1006
  • [49] Audit of Eye Care for Ventilated Patients in Intensive Treatment Unit During COVID-19 Pandemic
    Dhanapala, Muditha
    Sabaretnam, Suganya
    SRI LANKAN JOURNAL OF ANAESTHESIOLOGY, 2021, 29 (01): : 34 - 38
  • [50] Palliative Care Impact on COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation
    Grouls, Astrid
    Nwogu-Onyemkpa, Eberechi
    Guffey, Danielle
    Chatterjee, Subhasis
    Herlihy, James P.
    Naik, Aanand D.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2022, 64 (04) : E181 - E187